Cornerstone Robotics

Cornerstone Robotics (CSR) is positioned at the intersection of Health Care and Robotics, dedicated to leveraging advanced technology to enhance patient care globally. Established in 2019, CSR operates out of its headquarters in Hong Kong S.a.r..

The company's core mission is to advance healthcare by empowering surgeons with cutting-edge surgical robotic systems. Their flagship product, an endoscopic surgical system, was developed in-house and has successfully passed clinical trials in both the Chinese Mainland and Hong Kong. The company's global reach is supported by innovation hubs in major cities including Hong Kong, Shenzhen, Beijing, Shanghai, London, and Portsmouth.

Recently, CSR secured a CNY800.00M Series B investment on 30 June 2023 led by prominent investors such as Lilly Asia Ventures, Qiming Venture Partners, K2VC, and Lenovo Capital. This injection is set to bolster CSR's efforts to pioneer and expand their next-generation surgical technologies worldwide, keeping them a cornerstone to better healthcare.